Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ankmy2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | Ankmy2 | Rat | 17beta-estradiol | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Estradiol affects the expression of ANKMY2 mRNA | CTD | PMID:22574217 | Ankmy2 | Rat | 17beta-estradiol | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ANKMY2 mRNA | CTD | PMID:31614463 | Ankmy2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ANKMY2 mRNA | CTD | PMID:27291303 | Ankmy2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ankmy2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANKMY2 mRNA | CTD | PMID:21570461|PMID:24680724 | Ankmy2 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANKMY2 mRNA | CTD | PMID:20188158 | Ankmy2 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of ANKMY2 protein | CTD | PMID:34915118 | Ankmy2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Ankmy2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of ANKMY2 mRNA | CTD | PMID:18648102 | Ankmy2 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Decitabine affects the expression of ANKMY2 mRNA | CTD | PMID:23300844 | Ankmy2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | Ankmy2 | Rat | aflatoxin B1 | decreases methylation | ISO | ANKMY2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ANKMY2 gene | CTD | PMID:27153756 | Ankmy2 | Rat | all-trans-retinoic acid | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ANKMY2 mRNA | CTD | PMID:33167477 | Ankmy2 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | Ankmy2 | Rat | antirheumatic drug | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ANKMY2 mRNA | CTD | PMID:24449571 | Ankmy2 | Rat | aristolochic acid A | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ANKMY2 mRNA | CTD | PMID:33212167 | Ankmy2 | Rat | arsane | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | arsenic atom | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | benzo[a]pyrene | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ANKMY2 protein | CTD | PMID:32717239 | Ankmy2 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANKMY2 mRNA | CTD | PMID:19150397 | Ankmy2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ANKMY2 mRNA | CTD | PMID:25181051 | Ankmy2 | Rat | bisphenol A | decreases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ANKMY2 mRNA | CTD | PMID:33221593 | Ankmy2 | Rat | bisphenol F | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Ankmy2 | Rat | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of ANKMY2 promoter | CTD | PMID:22457795 | Ankmy2 | Rat | calcitriol | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of ANKMY2 mRNA | CTD | PMID:16002434 | Ankmy2 | Rat | CGP 52608 | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ANKMY2 gene] | CTD | PMID:28238834 | Ankmy2 | Rat | chlorpyrifos | decreases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ANKMY2 mRNA | CTD | PMID:37019170 | Ankmy2 | Rat | cisplatin | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ANKMY2 mRNA | CTD | PMID:27594783 | Ankmy2 | Rat | cisplatin | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of ANKMY2 mRNA | CTD | PMID:23300844 | Ankmy2 | Rat | copper(II) sulfate | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ANKMY2 mRNA | CTD | PMID:19549813 | Ankmy2 | Rat | cyclosporin A | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ANKMY2 mRNA | CTD | PMID:20106945 | Ankmy2 | Rat | dexamethasone | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Ankmy2 | Rat | Dibutyl phosphate | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ANKMY2 mRNA | CTD | PMID:37042841 | Ankmy2 | Rat | dicrotophos | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ANKMY2 mRNA | CTD | PMID:28302478 | Ankmy2 | Rat | dorsomorphin | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ankmy2 | Rat | epoxiconazole | decreases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ANKMY2 mRNA | CTD | PMID:35436446 | Ankmy2 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of ANKMY2 mRNA | CTD | PMID:24793618 | Ankmy2 | Rat | indometacin | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Ankmy2 | Rat | ivermectin | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ANKMY2 protein | CTD | PMID:32959892 | Ankmy2 | Rat | manganese atom | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | manganese(0) | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | manganese(II) chloride | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | niclosamide | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of ANKMY2 mRNA | CTD | PMID:36318118 | Ankmy2 | Rat | nitrates | multiple interactions | ISO | Ankmy2 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANKMY2 more ... | CTD | PMID:35964746 | Ankmy2 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA | CTD | PMID:25729387 | Ankmy2 | Rat | paracetamol | affects expression | ISO | Ankmy2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ANKMY2 mRNA | CTD | PMID:17562736 | Ankmy2 | Rat | paracetamol | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ANKMY2 mRNA | CTD | PMID:21420995 | Ankmy2 | Rat | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | Ankmy2 | Rat | potassium chromate | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | Ankmy2 | Rat | potassium chromate | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | Ankmy2 | Rat | quercetin | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ANKMY2 mRNA | CTD | PMID:21632981 | Ankmy2 | Rat | resveratrol | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKMY2 mRNA | CTD | PMID:23557933 | Ankmy2 | Rat | SB 431542 | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ankmy2 | Rat | sodium arsenite | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ANKMY2 mRNA | CTD | PMID:38568856 | Ankmy2 | Rat | sodium arsenite | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ankmy2 | Rat | sodium arsenite | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ANKMY2 mRNA | CTD | PMID:34032870 | Ankmy2 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | Ankmy2 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA | CTD | PMID:15336504 | Ankmy2 | Rat | titanium dioxide | increases expression | ISO | Ankmy2 (Mus musculus) | 6480464 | titanium dioxide analog results in increased expression of ANKMY2 mRNA | CTD | PMID:25111187 | Ankmy2 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA | CTD | PMID:25729387 | Ankmy2 | Rat | trichostatin A | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ANKMY2 mRNA | CTD | PMID:26272509 | Ankmy2 | Rat | trichostatin A | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ankmy2 | Rat | triphenyl phosphate | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ANKMY2 mRNA | CTD | PMID:37042841 | Ankmy2 | Rat | valproic acid | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ANKMY2 mRNA | CTD | PMID:19101580|PMID:22083351|PMID:28001369|PMID:29154799 | Ankmy2 | Rat | valproic acid | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ANKMY2 mRNA | CTD | PMID:25979313 | Ankmy2 | Rat | valproic acid | decreases methylation | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ANKMY2 gene | CTD | PMID:29154799 | Ankmy2 | Rat | vorinostat | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | vorinostat results in increased expression of ANKMY2 mRNA | CTD | PMID:22083351 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















